✦ LIBER ✦

A double-blind clinical trial of fluvoxamine and imipramine in patients with primary depression

✍ Scribed by William Guy; William H. Wilson; Thomas A. Ban; Douglas L. King; Gregory Manov; Olaf K. Fjetland

Publisher: John Wiley and Sons
Year: 1984
Tongue: English
Weight: 568 KB
Volume: 4
Category: Article
ISSN: 0272-4391
DOI: 10.1002/ddr.430040203

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Clinical trial of adjunctive celecoxib t

Clinical trial of adjunctive celecoxib treatment in patients with major depression: a double blind and placebo controlled trial

✍ Shahin Akhondzadeh; Sara Jafari; Firoozeh Raisi; Abbas Ali Nasehi; Aboulfazl Gho 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 91 KB 👁 3 views

Clinical evaluation of alprazolam in pat

Clinical evaluation of alprazolam in patients with panic disorder: A double-blind comparison with imipramine

✍ U. Lepola; H. Heikkinen; R. Rimón; P. Riekkinen 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 404 KB 👁 1 views

The antipanic effect and tolerability of alprazolam and imipramine were compared during 9 weeks in 55 inpatients with panic disorder with or without agoraphobia. Both drugs decreased significantly the frequency of panic attacks, alprazolam as early as 3 weeks of treatment. The symptoms of generalize

A double-blind comparison of the efficac

A double-blind comparison of the efficacy and safety of paroxetine and imipramine in the treatment of depression with dementia

✍ Cornelius L. E. Katona; Brian N. Hunter; Julia Bray 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 150 KB 👁 2 views

Objectives. To compare the ecacy of paroxetine and imipramine prospectively in patients with coexisting depression and dementia. Methods. An 8-week, double-blind, parallel group trial comparing paroxetine 20±40 mg/day with imipramine 50±100 mg/day in 198 patients aged 60 years or over with a Montgo

Differences in clinical effect and toler

Differences in clinical effect and tolerance between fluvoxamine and paroxetine: A switching study in patients with depression

✍ Yutaro Suzuki; Nobuto Tsuneyama; Naoki Fukui; Takuro Sugai; Junzo Watanabe; Shin 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 67 KB

## Abstract ## Objective We examined whether discontinuation and the responses to fluvoxamine (FLV) administration could predict the subsequent discontinuation and the responses to paroxetine (PRX) in patients with depression. ## Methods The subjects comprised 106 outpatients who were diagnosed

Clinical efficacy and safety of etanerce

Clinical efficacy and safety of etanercept versus sulfasalazine in patients with ankylosing spondylitis: A randomized, double-blind trial

✍ Juergen Braun; Irene E. van der Horst-Bruinsma; Feng Huang; Ruben Burgos-Vargas; 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 178 KB 👁 2 views

A double-blind placebo-controlled compar

A double-blind placebo-controlled comparison of phenelzine and imipramine in the treatment of bulimia in atypical depressives

✍ Rothschild, Rachel ;Quitkin, H. Matthew ;Quitkin, Frederic M. ;Stewart, Jonathan 📂 Article 📅 1994 🏛 Wiley (John Wiley & Sons) 🌐 English ⚖ 606 KB